| Title: |
Indicators to evaluate quality of care in head and neck cancer in Spain. |
| Authors: |
Hernández, Juan Jesús Cruz, Arrula, Virginia Arrazubi, Álvarez, Yolanda Escobar, Castaño, Almudena García, de Castro, Juan José Grau, Docampo, Lara Iglesias, Sorrosal, Julio Lambea, Segura, Pedro Pérez, Domínguez, Antonio Rueda, Campos-Lucas, Francisco J., Rodríguez, Irene Santamaría, Bessa, Maria, Gratal, Paula, Caballero-Martínez, Fernando, Martín, Diana Monge, Antón-Rodríguez, Cristina, López, Rafael |
| Source: |
Clinical & Translational Oncology; May2024, Vol. 26 Issue 5, p1089-1097, 9p |
| Abstract: |
Purpose: This study aimed to develop a set of criteria and indicators to evaluate the quality of care of patients with head and neck cancer (HNC). Methods: A systematic literature review was conducted to identify valuable criteria/indicators for the assessment of the quality of care in HNC. With the aid of a technical group, a scientific committee of oncologists specialised in HNC used selected criteria to propose indicators that were evaluated with a two-round Delphi method. Indicators on which consensus was achieved were then prioritised by the scientific committee to develop a final set of indicators. Results: We proposed a list of 50 indicators used in the literature or developed by us to be evaluated with a Delphi method. There was consensus on the appropriateness of 47 indicators in the first round; the remaining 3 achieved consensus in the second round. The 50 indicators were scored to prioritise them, leading to a final selection of 29 indicators related to structure (3), process (22), or outcome (4) and covering diagnosis, treatment, follow-up, and health outcomes in patients with HNC. Easy-to-use index cards were developed for each indicator, with their criterion, definition, formula for use in real-world clinical practice, rationale, and acceptable level of attainment. Conclusions: We have developed a set of 29 evidence-based and expert-supported indicators for evaluating the quality of care in HNC, covering diagnosis, treatment, follow-up, and health outcomes. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical & Translational Oncology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
